Table 4.
The literature review results for autoimmune conditions triggered following the COVID-19.
| Autoimmune Disease | Reference | |
|---|---|---|
| 1 | Antiphospholipid syndrome | (42–44) |
| 2 | Guillain-Barr´e syndrome | (45–47) |
| 3 | Miller Fisher syndrome | (48, 49) |
| 4 | Polyneuritis cranialis | (49) |
| 5 | Thyroid function | (50, 51) |
| 6 | Graves’ disease | (52) |
| 7 | Vasculitis | (53) |
| 8 | Kawasaki disease | (54) |
| 9 | Type 1 Diabetes | (55–57) |
| 10 | Autoimmune hemolytic anemia | (58–60) |
| 11 | Immune thrombocytopenic purpura | (61, 62) |
| 12 | Systemic lupus erythematosus | (63, 64) |
| 13 | Post orthostatic tachycardia syndrome | (65) |
| 14 | Viral arthritis | (66, 67) |
| 15 | Myasthenia gravis | (68) |
| 16 | Autoimmune encephalitis | (69) |
| 17 | Rheumatoid arthritis | (70, 71) |
| 18 | Autoimmune limbic encephalitis | (72) |
| 19 | Multiple sclerosis | (73, 74) |
| 20 | Inflammatory Bowel Disease (Crohn’s disease and ulcerative colitis) | (75) |
| 21 | Ankylosing spondylitis | (76) |